Several studies have shown, via acetylcholine esterase inhibitor assays, that numerous pure compounds have anti-dementia activities (Ho et al., 2011; Natarajan et al., 2013), but no compounds have been clinically approved. The gene discussed is ACHE; the disease is dementia.